Table 1 Characteristics of the patients according system involvement of the whole cohort n = 56
From: Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy
Variable | Overall n = 56° | Respiratory involvement n = 17 | Systemic involvement n = 24 | Digestive involvement n = 8 | Neurological N = 4 |
|---|---|---|---|---|---|
Age in years, Median (IQR)* | 39 (31–47) | 39 (31–47) | 38 (31–50) | 35 (28–42) | 36 (34–51) |
Sex, male n, (%) | 44 (79) | 13 (78) | 21 (87) | 7 (88) | 1 (25) |
On HAART**, yes n, (%) | 14 (25) | 1 (6) | 7 (29) | 5 (63) | 4 (100) |
Fever n, (%) | 33 (59) | 12 (71) | 18 (75) | 1 (13) | 2 (50) |
ICU admission n, (%) | 19 (34) | 8 (47) | 7 (30) | 1 (13) | 2 (50) |
Mechanical Ventilation, yes n, (%) | 12 (21) | 6 (35%) | 3 (13) | 1 (13) | 1 (25) |
Mortality n, (%) | 10 (18%) | 3 (18%) | 4 (17) | 1 (13) | 1 (25) |
Cd4 cells/mm3, Median (IQR)* | 47 (18–85) | 19 (10–45) | 63 (22–97) | 67 (43–206) | 23 (14–69) |
Cd8 cells/mm3, Median (IQR)* | 514 (272–828) | 356 (189–860) | 514 (289–653) | 727 (494–941) | 319 (123–649) |
HIV viral load cop/ml × 105 Median, (IQR)* | 2.84 (0.5–6.8) | 1.27 (0.49–4.03) | 3.1 (0.8–9.1) | 6.6 (0.95–18.4) | 1.21 (0.1–4.8) |
CMV*** blood VL Median (IQR)*copies/ml × 103 | 3.7 (1.09–24.9) | 3.9 (1.2–43.6) | 1.2 (0.7–13) | 1.2 (0.56–31.1) | 0.4 (0.1–122) |
LDH° IU/L values [< 240], Median (IQR)* | 657 (463–1000) | 891 (597–1333) | 650 (427–809) | 578 (441–865) | 430 (351–454) |